NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Prolium Bioscience, Inc. (Prolium), a clinical stage biotechnology company, today announced that the first patient has been dosed in a multinational, ...
Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countries Recently completed Phase 1 Single Ascending Dose study of PRO-203 in healthy ...
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health and biosciences — today announced the ...
Multi-omics analyses identifies linoleic acid as a critical fatty acid which is modulated by ART26.12SOLANA BEACH, Calif., ...
Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted ...
Experts break it down.
HSBC upgraded Gilead Sciences Inc. GILD on Monday, citing that the consensus is ‘too pessimistic’ in its assumptions of ...
Detailed price information for Interpace Biosciences Inc (IDXG) from The Globe and Mail including charting and trades.
When it comes to traveling for medi spas and biohacking retreats, only some clinics are actually worth their salt. Here's ...
Major stock indexes were mixed in early trading Tuesday, a day after the Dow Jones Industrial Average set a new closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results